Showing results (191-200 of 316) with videos related to

Sort By:
Pageof 32
Trials|October 31, 2021
Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study)Lucía Lavín-Alconero, Tatiana Fernández-Lanas, Paula Iruzubieta-Coz, et al.
Gastroenterology|April 29, 2020
JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic InfectionFabien Zoulim, Oliver Lenz, Joris J Vandenbossche, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2024
Endoscopic Sleeve Gastroplasty Plus Lifestyle Intervention in Patients With Metabolic Dysfunction-associated Steatohepatitis: A Multicentre, Sham-controlled, Randomized TrialJavier Abad, Elba Llop, María Teresa Arias-Loste, et al.
The Journal of Clinical Endocrinology and Metabolism|December 21, 2021
Vitamin D Status in Hospitalized Patients with SARS-CoV-2 InfectionJosé L Hernández, Daniel Nan, Marta Fernandez-Ayala, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2020
Vitamin D Status in Hospitalized Patients with SARS-CoV-2 InfectionJosé L Hernández, Daniel Nan, Marta Fernandez-Ayala, et al.
Communications Medicine|May 23, 2022
Vaccinate fast but leave no one behind: a call to action for COVID-19 vaccination in SpainJeffrey V Lazarus, Quique Bassat, Javier Crespo, et al.
BMC Public Health|November 15, 2024
Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate studyFernando Chacón, Luis Morano, Jordi Navarro, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 29, 2021
Non-malignant portal vein thrombosis in a cohort of cirrhotic patients: Incidence and risk factorsMarta Lopez-Gomez, Elba Llop, Angela Puente, et al.
Plos One|April 1, 2015
Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim studyManuel Romero-Gómez, Juan Turnes, Javier Ampuero, et al.
Journal of Clinical Medicine|September 9, 2023
Risk of Recurrence of Hepatocarcinoma after Liver Transplantation: Performance of Recurrence Predictive Models in a Cohort of Transplant PatientsAntonio Cuadrado, José Ignacio Fortea, Carlos Rodríguez-Lope, et al.
Pageof 32